Sponsored
Proto Labs beats Q1 estimates with 10% revenue growth, but macro fears weigh. Is it a buy?
Santos' $160M PNG LNG project targets >50% IRR & <4yr payback. Brownfield expansion boosts capacity.
Moderna's revenue soars on UK deals, but litigation weighs. Costs down 26%, yet losses persist. Buy MRNA?
Australian business confidence edged up to -24 in April from -29 in March but remained deeply negative, as surging energy costs squeezed margins and conditions fell to their lowest since 2020, NAB data showed.
PBOC sets USD/ CNY central rate at 6.8426 (vs. estimate at 6.7945) PBOC CNY reference rate setting for the trading session ahead.
MU's 770% gain & 13x P/E vs. SNDK's 4000% gain & 24x P/E. AI boom fuels memory chip returns.
DNUT beats revenue, misses EPS. Margin up on franchise shift & cost cuts. Valuation at $627.5M.
Sponsored